Skip to main content
. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3

2.4. Analysis.

2.4

Comparison 2 ICS versus placebo, parallel‐group studies, greater than 2 months to 6 months (all doses), Outcome 4 Post‐bronchodilator FEV1 (change from baseline).